You are here:

  • Home
  • Products
  • Product Overview

  • Product Overview

AOP Orphan Contact

AOP Orphan worldwide

Wilhelminenstraße 91/IIf
1160 Vienna, Austria
office(at)aoporphan.com

Product Overview


AOP Orphan's focus is on Rare Diseases. The portfolio comprises products in the following therapeutic areas: hematology, oncology, cardio-pulmonology, neurology, psychiatry and genetic disorders. AOP Orphan’s strategic goal is to constantly deliver new treatment options with respect to Rare Diseases.

Hematology & Oncology

Thromboreductin (anagrelide) is used to reduce an elevated blood platelet count (thrombocyte count) in patients with essential thrombocythemia. An excessively high blood platelet count can lead to vascular and blood coagulation disorders. By reducing the blood platelet count, one reduces the risk of these severe disorders.

Thromboreductin (anagrelide) is used to reduce an elevated blood platelet count (thrombocyte count) in patients with essential thrombocythemia. An excessively high blood platelet count can lead to vascular and blood coagulation disorders. By reducing the blood platelet count, one reduces the risk of these severe disorders.

Drug facts
Active ingredients:
Anagrelide HCl
Availability

Busilvex (busulfan) is a concentrate used to prepare a solution for infusion and is used by adults in combination with cyclophosphamide as a preparative treatment before stem cell transplantation.

Pierre Fabre is the MA-Holder and AOP Orphan has the distribution rights

Drug facts
Active ingredients:
Busulfan
Availability

Canemes® enthält den Wirkstoff Nabilone, eine synthetisch hergestellte Substanz aus der Gruppe derCannabinoide (Inhaltsstoff der Hanfpflanze). Canemes® verhindert Übelkeit und Erbrechen bei Patienten unter Chemotherapie (CINE) für bösartige Gewebsneubildungen und wird eingesetzt, wenn andere Medikamente nicht entsprechend wirken.

Canemes® enthält den Wirkstoff Nabilone, eine synthetisch hergestellte Substanz aus der Gruppe derCannabinoide (Inhaltsstoff der Hanfpflanze). Canemes® verhindert Übelkeit und Erbrechen bei Patienten unter Chemotherapie (CINE) für bösartige Gewebsneubildungen und wird eingesetzt, wenn andere Medikamente nicht entsprechend wirken.

Drug facts
Active ingredients:
Nabilone
Availability

Willfact is a human von Willebrand factor used to prevent and treat bleeding or to control bleeding during surgery for von Willebrand disease if desmopressin has no effect or is contraindicated.



Willfact may (should) not be used to treat hemophilia A.

Willfact is a human von Willebrand factor used to prevent and treat bleeding or to control bleeding during surgery for von Willebrand disease if desmopressin has no effect or is contraindicated.



Willfact may (should) not be used to treat hemophilia A.

Drug facts
Active ingredients:
Human von Willebrand Faktor
Availability
atAustria
Cardiology & Pulmonology

The active ingredient of remodulin® is treprostinil. Remodulin® is used to treat idiopathic or hereditary pulmonary arterial hypertension (PAH) in patients with medium to severe symptoms.

The active ingredient of remodulin® is treprostinil. Remodulin® is used to treat idiopathic or hereditary pulmonary arterial hypertension (PAH) in patients with medium to severe symptoms.

Drug facts
Active ingredients:
Treprostinil
Availability
Middle East
deGermany
ltLithuania

Lojuxta® contains the active ingredient called lomitapide. Lomitapide is a “lipid-modifying agent” which works by blocking the action of “microsomal triglyceride transfer protein”. This protein can found be in the liver and intestinal cells where it is involved in assembling fatty substances into larger particles, which are then released into the blood stream. By blocking this protein, this medicine lowers the levels of fats and cholesterol (lipids) in the blood.

Lojuxta® contains the active ingredient called lomitapide. Lomitapide is a “lipid-modifying agent” which works by blocking the action of “microsomal triglyceride transfer protein”. This protein can found be in the liver and intestinal cells where it is involved in assembling fatty substances into larger particles, which are then released into the blood stream. By blocking this protein, this medicine lowers the levels of fats and cholesterol (lipids) in the blood.

Drug facts
Active ingredients:
Lomitapide
Availability
atAustria
czCzech Republic
eeEstonia
huHungary
ltLithuania
roRomania
skSlovakia

Tadim® contains colistimethate sodium, which is an antibiotic used to treat Pseudomonas aeruginosa infections. This is a very common type of bacteria which infects the lungs of almost every mucoviscidosis patient at some point or other. If the infection cannot be brought under control, it continues to damage the lungs, which leads to other problems.



Tadim® is inhaled into the lungs, which helps the antibiotic to combat the bacteria causing such infections more effectively.

Tadim® contains colistimethate sodium, which is an antibiotic used to treat Pseudomonas aeruginosa infections. This is a very common type of bacteria which infects the lungs of almost every mucoviscidosis patient at some point or other. If the infection cannot be brought under control, it continues to damage the lungs, which leads to other problems.



Tadim® is inhaled into the lungs, which helps the antibiotic to combat the bacteria causing such infections more effectively.

Drug facts
Active ingredients:
Colistimethat-Sodium
Availability
Neurology & Psychiatry

Tetmodis (Tetrabenazine) is used as symptomatic therapy in the treatment of hyperkinetic motor disorders in Huntington’s disease. Tetrabenazine is also used in etiologies such as tardive dyskinesia, tics and dystonia.

Tetmodis (Tetrabenazine) is used as symptomatic therapy in the treatment of hyperkinetic motor disorders in Huntington’s disease. Tetrabenazine is also used in etiologies such as tardive dyskinesia, tics and dystonia.

Drug facts
Active ingredients:
Tetrabenazine
Availability
huHungary

The use of Ospolot to treat epilepsy should only be prescribed by neuropediatricians with experience in treating epilepsy.

Ospolot contains the active ingredient sultiame. Before beginning with treatment, a detailed differential diagnosis is carried out with other forms of epilepsy in children. 

Drug facts
Active ingredients:
Sultiame
Availability

Adasuve is indicated for the rapid control of mild-to-moderate agitation (increased, unproductive physical activity coupled with internal tension) in adult patients with schizophrenia or biopolar disorder. Patients should receive regular treatment immediately after control of acute agitation symptoms. 

Adasuve is indicated for the rapid control of mild-to-moderate agitation (increased, unproductive physical activity coupled with internal tension) in adult patients with schizophrenia or biopolar disorder. Patients should receive regular treatment immediately after control of acute agitation symptoms. 

Drug facts
Active ingredients:
Loxapine
Availability
atAustria
czCzech Republic
eeEstonia
ltLithuania
skSlovakia